Myeloproliferative disease

Results: 96



#Item
11  Dr James Vardiman Professor Emeritus Department of Pathology University of Chicago

1 Dr James Vardiman Professor Emeritus Department of Pathology University of Chicago

Add to Reading List

Source URL: whobluebooks.iarc.fr

Language: English - Date: 2015-10-29 10:08:25
2Molecular Diagnosis of Myeloid Neoplasias and Solid Tumors First report of mutations detected in the gene for NF-E2 Technology Myeloproliferative Neoplasms (MPN) are a group of several distinct, but clinically related ma

Molecular Diagnosis of Myeloid Neoplasias and Solid Tumors First report of mutations detected in the gene for NF-E2 Technology Myeloproliferative Neoplasms (MPN) are a group of several distinct, but clinically related ma

Add to Reading List

Source URL: www.campus-technologies.de

Language: English - Date: 2015-02-19 09:31:03
3Phase 2 trial of PRM-151, an anti-fibrotic agent, in patients with myelofibrosis: Stage 1 results Srdan Verstovsek1, Ruben Mesa2, Lynda Foltz3, Vikas Gupta4, John Mascarenhas5, Ellen Ritchie6, Ronald Hoffman5, Richard

Phase 2 trial of PRM-151, an anti-fibrotic agent, in patients with myelofibrosis: Stage 1 results Srdan Verstovsek1, Ruben Mesa2, Lynda Foltz3, Vikas Gupta4, John Mascarenhas5, Ellen Ritchie6, Ronald Hoffman5, Richard

Add to Reading List

Source URL: www.promedior.com

Language: English - Date: 2015-02-08 17:25:15
4Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca

Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca

Add to Reading List

Source URL: www.novartis.ca

Language: English - Date: 2015-05-13 10:22:06
5Phase 2 Trial of PRM-151, an Anti-Fibrotic Agent, in Patients with Myelofibrosis: Stage 1 Results S. Verstovsek1, R. Mesa2, L. Foltz3, V. Gupta4, J. Mascarenhas5, E. Ritchie6, R. Hoffman5, R. Silver6, W. J. Hong8, M. Kre

Phase 2 Trial of PRM-151, an Anti-Fibrotic Agent, in Patients with Myelofibrosis: Stage 1 Results S. Verstovsek1, R. Mesa2, L. Foltz3, V. Gupta4, J. Mascarenhas5, E. Ritchie6, R. Hoffman5, R. Silver6, W. J. Hong8, M. Kre

Add to Reading List

Source URL: www.promedior.com

Language: English - Date: 2014-06-13 01:07:42
6Microsoft Word - Fact Sheet - Updated and expanded MPN cluster investigation in northeastern Pennsylvania

Microsoft Word - Fact Sheet - Updated and expanded MPN cluster investigation in northeastern Pennsylvania

Add to Reading List

Source URL: www.atsdr.cdc.gov

Language: English - Date: 2015-03-19 12:50:23
7New York State Cancer Registry Guide to Determine Reportability for Physician Medical Practices

New York State Cancer Registry Guide to Determine Reportability for Physician Medical Practices

Add to Reading List

Source URL: www.health.ny.gov

Language: English - Date: 2011-04-06 14:08:05
8Gillian Rozenberg  Training Workshops ABN

Gillian Rozenberg Training Workshops ABN

Add to Reading List

Source URL: myqapdocs.s3.amazonaws.com

Language: English - Date: 2015-03-29 22:59:31
9Original Article Updated and Expanded Study of Polycythemia Vera   and Other Myeloproliferative Neoplasms

Original Article Updated and Expanded Study of Polycythemia Vera and Other Myeloproliferative Neoplasms

Add to Reading List

Source URL: www.atsdr.cdc.gov

Language: English - Date: 2015-03-19 12:50:24
10NonChem Qualitative 1Q2015.xlsx

NonChem Qualitative 1Q2015.xlsx

Add to Reading List

Source URL: www.aab-pts.org

Language: English - Date: 2015-04-15 17:39:34